Overview

Safety and Tolerability of Seroguard Use

Status:
Completed

Trial end date:
2015-10-04

Target enrollment:

Participant gender:

Summary

The performed study of safety and tolerability of Seroguard, solution (JSC Pharmasyntez, Russia) in patients, undergoing planned laparoscopic cholecystectomy, demonstrated that patients from the both groups had the similar safety profile

Phase:

Phase 1

Details

Lead Sponsor:

Pharmasyntez

Collaborator:

Sciencefiles